Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

SK Securities

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$30M
Portfolio companies 5
Rounds per year 0.07
Lead investments 2
Key employees Soon

Areas of investment

  • Therapeutics
  • Biotechnology
  • B2B
  • Beauty
  • Internet
Summary

The average startup value when the investment from SK Securities is 100-500 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2016. The common things for fund are deals in the range of 10 - 50 millions dollars.

The standard case for the fund is to invest in rounds with 2 partakers. Despite the SK Securities, startups are often financed by KTB Network, Industrial Bank of Korea. The meaningful sponsors for the fund in investment in the same round are Industrial Bank of Korea, Kiwoom Investment. In the next rounds fund is usually obtained by Premier Partners, POSCO Venture Capital, Korea Kolmar Co..

Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most successful fund investment fields, there are Beauty, B2B. Among the most popular portfolio startups of the fund, we may highlight B2Link, B2Link. The fund has exact preference in a number of founders of portfolio startups.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AT Capital Group Central, Central Region, Singapore
BIG BETS -
Dentsu Ventures Chiyoda, Japan
First Media Indonesia, Jakarta, Jakarta Raya
Graphite Capital England, London, United Kingdom
Lauxera Capital Partners France, Ile-de-France, Paris
Manatt Ventures New York, New York, United States
Niantic California, San Francisco, United States
Omicron Media Florida, United States, Winter Park
Protege VirtualManagement -
SonicWALL California, Santa Clara, United States
SWL Healthcare Ventures -
Three Cairns Group New York, New York, United States
W Investments Canada, Montréal, Quebec
Yanchuang Capital Chaoyang, China, Liaoning
Zuiyou Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

PineTree Therapeutics

Medical
Therapeutics
Wellness
$23M07 Jun 2022 Cambridge, Massachusetts, United States

Mana Therapeutics

Biotechnology
$7M30 Nov 2021 Arlington, Virginia, United States

Cerecin

Biotechnology
Health Care
Life Science
Therapeutics
$30M18 Oct 2021 Singapore, Central Region, Singapore

Apps
Information Technology
Marketing
Mobile
Software
$87M12 Nov 2019 Seongnam-si

B2Link

B2B
Beauty
E-Commerce
Internet
$4M24 Feb 2016 South Korea

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent SK Securities?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: